Shoulder Innovations (NYSE:SI) Major Shareholder Healthcare Holding B.V. Gilde Sells 1,196 Shares

Shoulder Innovations, Inc. (NYSE:SI) major shareholder Healthcare Holding B.V. Gilde sold 1,196 shares of the company’s stock in a transaction dated Wednesday, August 26th. The stock was sold at an average price of $22.60, for a total transaction of $27,029.60. Following the completion of the sale, the insider directly owned 2,185,914 shares in the company, valued at $49,401,656.40. This represents a 0.05% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Large shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.

Healthcare Holding B.V. Gilde also recently made the following trade(s):

• On Monday, August 24th, Healthcare Holding B.V. Gilde sold 681 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.62, for a total transaction of $15,404.22.
• On Friday, August 21st, Healthcare Holding B.V. Gilde sold 20,516 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.61, for a total transaction of $463,866.76.
• On Thursday, August 20th, Healthcare Holding B.V. Gilde sold 3,900 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.60, for a total transaction of $88,140.00.
• On Thursday, August 6th, Healthcare Holding B.V. Gilde sold 2,095 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.60, for a total value of $47,347.00.
• On Wednesday, August 5th, Healthcare Holding B.V. Gilde sold 7,338 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.64, for a total value of $166,132.32.
• On Tuesday, August 4th, Healthcare Holding B.V. Gilde sold 99,812 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.77, for a total value of $2,272,719.24.
• On Monday, August 3rd, Healthcare Holding B.V. Gilde sold 10,751 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.71, for a total transaction of $244,155.21.
• On Friday, July 31st, Healthcare Holding B.V. Gilde sold 20,034 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.73, for a total transaction of $455,372.82.
• On Thursday, July 30th, Healthcare Holding B.V. Gilde sold 28,245 shares of Shoulder Innovations stock. The shares were sold at an average price of $23.36, for a total transaction of $659,803.20.

Shoulder Innovations Stock Down 0.9%

NYSE SI traded down $0.20 during mid-day trading on Friday, reaching $21.07. The stock had a trading volume of 51,957 shares, compared to its average volume of 96,070. The stock has a market cap of $438.68 million and a PE ratio of -10.97. Shoulder Innovations, Inc. has a 1 year low of $10.92 and a 1 year high of $24.59. The company has a debt-to-equity ratio of 0.12, a current ratio of 10.71 and a quick ratio of 8.92. The company has a fifty day moving average price of $21.25 and a 200 day moving average price of $16.79.

Shoulder Innovations (NYSE:SI) last posted its earnings results on Thursday, August 6th. The company reported ($0.49) EPS for the quarter, missing analysts’ consensus estimates of ($0.46) by ($0.03). The business had revenue of $17.18 million during the quarter. Shoulder Innovations had a negative return on equity of 23.61% and a negative net margin of 58.33%. On average, research analysts expect that Shoulder Innovations, Inc. will post -1.9 earnings per share for the current year.

Institutional Trading of Shoulder Innovations

Several institutional investors and hedge funds have recently modified their holdings of SI. California State Teachers Retirement System boosted its holdings in Shoulder Innovations by 412.4% in the 2nd quarter. California State Teachers Retirement System now owns 2,941 shares of the company’s stock worth $60,000 after buying an additional 2,367 shares during the period. Compass Financial Management LLC bought a new stake in Shoulder Innovations during the second quarter valued at about $30,000. Bank of America Corp DE lifted its position in shares of Shoulder Innovations by 43.7% in the first quarter. Bank of America Corp DE now owns 26,983 shares of the company’s stock valued at $392,000 after acquiring an additional 8,205 shares in the last quarter. Royal Bank of Canada boosted its stake in shares of Shoulder Innovations by 7,046.3% in the first quarter. Royal Bank of Canada now owns 53,883 shares of the company’s stock worth $783,000 after acquiring an additional 53,129 shares during the period. Finally, KCM Capital Inc bought a new position in shares of Shoulder Innovations in the first quarter worth about $509,000.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the stock. Piper Sandler reissued an “overweight” rating and set a $25.00 price objective (up from $19.00) on shares of Shoulder Innovations in a report on Friday, August 7th. Weiss Ratings upgraded Shoulder Innovations from a “sell (d-)” rating to a “sell (d)” rating in a research note on Monday, August 3rd. BTIG Research upped their price objective on Shoulder Innovations from $24.00 to $26.00 and gave the company a “buy” rating in a research report on Friday, August 7th. Finally, UBS Group increased their price target on shares of Shoulder Innovations from $27.00 to $28.00 and gave the stock a “buy” rating in a research report on Monday, August 10th. Five analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $25.50.

About Shoulder Innovations

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.